Lv11
20 积分 2025-11-30 加入
JAK inhibitor selectivity: new opportunities, better drugs?
34分钟前
待确认
VX-509 (Decernotinib), an Oral Selective JAK-3 Inhibitor, in Combination With Methotrexate in Patients With Rheumatoid Arthritis
5小时前
已完结
Discovery of VX-509 (Decernotinib): A Potent and Selective Janus Kinase 3 Inhibitor for the Treatment of Autoimmune Diseases
5小时前
已完结
Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)
6小时前
已完结
皖公网安备34019202002308
